About this trial
Subarachnoid hemorrhage (SAH) represents a significant proportion of hemorrhagic strokes. Severe SAH in elderly patients is associated with poorer outcomes compared to younger cohorts. Better characterization of both short- and long -term prognosis in these patients is necessary to facilitate medical decision-making in the intensive care unit (ICU)
Primary Objective:
The primary objective is to identify prognostic factors associated with poor functional outcome or death at 6 months (± 2 months) in elderly patients admitted to the ICU for SAH.
Secondary Objectives:
To evaluate in-hospital mortality among elderly patients admitted to the ICU for SAH.
To describe the causes of in-hospital death (brain death, withholding/withdrawal of life-sustaining treatment \[WOLST\], other medico-surgical causes) in elderly patients admitted to the ICU for SAH.
To describe the care trajectory following hospital discharge for elderly patients admitted to the ICU for SAH.
To evaluate the mean length of stay in the ICU and in the hospital (acute care) for elderly patients admitted to the ICU for SAH.
To identify prognostic factors associated with poor functional outcome or death at 1 year in elderly patients admitted to the ICU for SAH.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Patients hospitalized in ICU for aneurysmal subarachnoid hemorrhage
Aged 70 years or over the day of admission in ICU
Between Juin 30, 2021 and Juin 30, 2025
Disqualifiers
Decline to participate
Trial population
Adult patients admitted in ICU for aneurysmal subarachnoid hemorrhage in 4 University Hospital Centers in France (CHU Nancy, CHU Reims, HC de Lyon, CHU Lille) between Juin 30, 2021 et Juin 30, 2025
Trial design
Cohort
Retrospective
Treatments tested in this trial
Not listed
Trial groups
Trial outcomes
Primary outcomes
Modified Rankin Scale (MRS) et 6 months
MRS : scale from 1(no symptoms) to 6 (dead) Good outcome : 0 - 2 Bad outcome: 3 - 6 The MRS grade is either collected if already available in the medical file or estimated retrospectively based on the patient neurological evaluation.
Secondary outcomes
Intrahospital mortality
Intrahospital mortality = percentage of deaths occuring during the initial hospitalisation (in the ICU and the neurosurgical/neurological ward)
Cause of intrahospital death
Percentage of the following categories: cerebral death, WOLST, surgical causes and medical causes
Destination upon hospital discharge
Percentage of the following categories: Discharge to Home versus Rehabilitation Unit versus Another Inpatient Ward (non-neurosurgical)
Modified Rankin Scale upon discharge from hospital.
MRS retrieved or estimated from patient's file data at the moment of ICU or neurosurgical ward discharge.
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
This trial is not recruiting at the moment. You can still explore other options: